NASDAQ: PTIX
Protagenic Therapeutics Inc Stock Ownership - Who owns Protagenic Therapeutics?

Insider buying vs selling

Have Protagenic Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PTIX insiders and whales buy or sell their stock.

PTIX Shareholders

What type of owners hold Protagenic Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Alexander K. Arrow7.78%45,815$127.37kInsider
Osaic Holdings Inc3.64%21,414$59.53kInstitution
Virtu Financial LLC3.19%18,808$52.29kInstitution
Citigroup Inc0.07%390$1.08kInstitution
Cwm LLC0.00%1$2.78Institution
Harbor Investment Advisory LLC0.00%1$2.78Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

PTIX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PTIX6.90%7.78%
PBM3.05%96.95%
WINT0.00%100.00%Net Buying
AIM0.01%99.99%Net BuyingNet Buying
ONCO0.00%100.00%

Protagenic Therapeutics Stock Ownership FAQ

Who owns Protagenic Therapeutics?

Protagenic Therapeutics (NASDAQ: PTIX) is owned by 6.90% institutional shareholders, 7.78% Protagenic Therapeutics insiders, and 85.33% retail investors. Alexander K. Arrow is the largest individual Protagenic Therapeutics shareholder, owning 45,815.00 shares representing 7.78% of the company. Alexander K. Arrow's Protagenic Therapeutics shares are currently valued at $140.65k.

If you're new to stock investing, here's how to buy Protagenic Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.